Accordingly, a minor fraction of CTSB-overexpressing cells in ParvOryx-treated patients displayed a non-macrophage EGFR-positive phenotype, suggesting that endogenous CTSB induction may also contribute to tumor cell killing. This evidence concerns the gene CTSB and neoplasm.